Related Experiment Video
Updated: Oct 8, 2026

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
Monoclonal antibody 123C3, identifying small cell carcinoma phenotype in lung tumours, recognizes mainly, but not
D J Schol1, W J Mooi, A A van der Gugten
1The Netherlands Cancer Institute (Antoni van Leeuwenhoekhuis), Division of Tumour Biology, Amsterdam.
Abstract:
Monoclonal antibody (MAb) 123C3 was raised against a membrane preparation of a small cell lung carcinoma (SCLC) specimen and its reactivity on normal tissues was tested. For the endocrine system, positive tissues included: pituitary and adrenal glands, thyrocytes and C-cells of the thyroid, the parathyroids, testis Leydig cells and pancreatic islets. In bronchioles and intestinal epithelium occasional cells, resembling Kultchitsky and enterochromaffin cells, were also positive. Epithelia like rete testis, mammary epithelium and gastric mucosa were positive in all or a significant proportion of cells. The positive cells in mammary epithelium and gastric mucosa were too numerous to represent the endocrine cells only. Neurons were usually negative or weakly positive. Their supportive cells such as glial, Schwann and ganglionic satellite cells were positive. Mesenchymal cell types, such as smooth muscle cells in most organs, cardiac muscle cells, the pia-arachnoid and ovarian stroma cells were positive, indicating that 123C3 reactivity is not confined to epithelial and neuron-supporting tissues. In Western blots of tumour specimens 123C3 recognized a 29 kDa band in reducing conditions, shifting to approximately 150 kDa in non-reducing conditions. Immunofluorescence on live tissue culture cells demonstrated presence of the antigen on the cell surface.
More Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
11:50Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN
Published on: April 3, 2026